This MedTech Company Has Market Expansion Opportunity, Says Bullish Analyst
TransMedics Group Inc (NASDAQ:TMDX) shares were climbing in early trading on Tuesday.The clinical trials for the company's Organ Care Systems for the heart, lung and liver have shown strong data, whic
Stephens Starts TransMedic at Overweight, Cities Organ Transport Technology
Expert Outlook: TransMedics Gr Through The Eyes Of 7 Analysts
In the preceding three months, 7 analysts have released ratings for TransMedics Gr (NASDAQ:TMDX), presenting a wide array of perspectives from bullish to bearish.The table below provides a concise ove
Express News | Transmedics Group Inc : Stephens Initiates With Overweight Rating; Price Target $151
TransMedics Group Initiated at Overweight by Stephens & Co.
TransMedics Group Initiated at Overweight by Stephens & Co.
Express News | Stephens & Co. Initiates Coverage On TransMedics Gr With Overweight Rating, Announces Price Target of $151
TransMedics Gr Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 13% Stephens & Co. → $151 Initiates Coverage On → Overweight 05/01/2024 -12.44% Canaccord Genui
Form 144 | TransMedics(TMDX.US) Officer Proposes to Sell 280.02K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 3, $TransMedics(TMDX.US)$ Officer Gordon Stephen intends to sell 2,060 shares of its common stock on Jun 3, with a total market value of approximately $280.02K. Gordon St
Insider Sale: Director David Weill Sells Shares of TransMedics Group Inc (TMDX)
TransMedics(TMDX.US) Director Sells US$168.99K in Common Stock
$TransMedics(TMDX.US)$ Director Weill David sold 1,193 shares of common stock on May 29, 2024 at an average price of $141.65 for a total value of $168.99K.Source: Announcement What is statement of cha
TransMedics(TMDX.US) Officer Sells US$2.83 Million in Common Stock
$TransMedics(TMDX.US)$ Officer Gordon Stephen sold 20,000 shares of common stock on May 29, 2024 at an average price of $141.4 for a total value of $2.83 million.Source: Announcement What is statement
The 3.9% Return This Week Takes TransMedics Group's (NASDAQ:TMDX) Shareholders Three-year Gains to 460%
Form 144 | TransMedics(TMDX.US) Director Proposes to Sell 168.98K in Common Stocks
SEC FILLINGS DISCLOSED/ May 29, $TransMedics(TMDX.US)$ Director Weill David intends to sell 1,193 shares of its common stock on May 29, with a total market value of approximately $168.98K. Weill Dav
Form 144 | TransMedics(TMDX.US) Officer Proposes to Sell 2.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 29, $TransMedics(TMDX.US)$ Officer Gordon Stephen intends to sell 20,000 shares of its common stock on May 29, with a total market value of approximately $2.74 million. G
Those Who Invested in TransMedics Group (NASDAQ:TMDX) Three Years Ago Are up 441%
We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many investors. But when you hold the right stock for the right time period, the rewards
Top 3 Health Care Stocks That May Crash In May
As of May 24, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator
TransMedics(TMDX.US) Officer Sells US$1.17 Million in Common Stock
$TransMedics(TMDX.US)$ Officer Hassanein Waleed H sold 8,625 shares of common stock on May 15, 2024 at an average price of $135.32 for a total value of $1.17 million.Source: Announcement What is state
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
Are You Looking for a Top Momentum Pick? Why TransMedics (TMDX) Is a Great Choice
TransMedics(TMDX.US) Director Sells US$324.55K in Common Stock
$TransMedics(TMDX.US)$ Director Weill David sold 2,500 shares of common stock on May 10, 2024 at an average price of $129.82 for a total value of $324.55K.Source: Announcement What is statement of cha
No Data